Will stopping aspirin early after my Percutaneous Coronary Intervention cause a heart attack?
After a percutaneous coronary intervention (PCI, or stent placement), doctors typically prescribe dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor (like ticagrelor or prasugrel) to prevent blood clots. Stopping aspirin early could increase the risk of a heart attack (myocardial infarction, MI), but recent research shows that if you switch to a P2Y12 inhibitor alone within the first 3 months, the risk of MI does not go up significantly, and the risk of bleeding goes down. The answer depends on whether you continue another antiplatelet medication.
What the research says
A large meta-analysis of 7 randomized trials involving 27,743 patients found that stopping aspirin within 3 months after PCI and continuing with a P2Y12 inhibitor alone (ticagrelor or prasugrel) did not significantly increase the risk of heart attack overall (HR=1.11, 95% CI 0.91-1.35, p=0.31) compared to continuing DAPT 5. However, stopping aspirin immediately (in-hospital or not starting it at all) did increase MI risk (HR=1.41) 5. The same analysis showed that P2Y12 inhibitor monotherapy reduced clinically relevant bleeding by 45% (HR=0.55) 5. Another study of 498 acute coronary syndrome patients who stopped aspirin early for various reasons and continued a P2Y12 inhibitor found no significant difference in the composite endpoint of death, recurrent ACS, revascularization, or stroke between those who took aspirin for ≤1 month vs. >1 month (adjusted HR 1.19, 95% CI 0.85-1.68) 7. A separate trial in patients with chronic coronary syndrome who were already on oral anticoagulation and had a stent placed more than 6 months earlier found that adding aspirin increased harm: the aspirin group had more deaths and no reduction in cardiovascular events 6. These findings suggest that early aspirin withdrawal is safe when a potent P2Y12 inhibitor is continued, but stopping all antiplatelet therapy would be dangerous.
What to ask your doctor
- Is it safe for me to stop aspirin early if I continue taking my P2Y12 inhibitor (ticagrelor or prasugrel)?
- What is my personal risk of bleeding versus heart attack, and how does that affect the decision to stop aspirin?
- How long should I stay on dual antiplatelet therapy before considering aspirin withdrawal?
- If I have other conditions (like needing blood thinners), should I stop aspirin earlier or later?
- Are there any signs or symptoms I should watch for that might indicate a problem after stopping aspirin?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.